resveratrol has been researched along with Alloxan Diabetes in 206 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 29 (14.08) | 29.6817 |
| 2010's | 136 (66.02) | 24.3611 |
| 2020's | 41 (19.90) | 2.80 |
| Authors | Studies |
|---|---|
| Bemis, JE; Carney, DP; Disch, JS; Gagne, DJ; Jirousek, MR; Lambert, PD; Lavu, S; Lynch, AV; Milne, JC; Ng, PY; Nunes, JJ; Olefsky, JM; Perni, RB; Schenk, S; Smith, JJ; Vu, CB | 1 |
| Akishita, M; Eto, M; Iijima, K; Ogawa, S; Ota, H; Ouchi, Y; Shirasawa, T; Tani, H; Tatefuji, T | 1 |
| Deng, B; Huang, L; Song, Y; Wang, Y; Yu, X; Zeng, K; Zhou, X | 1 |
| Guo, X; Hu, W; Huang, X; Li, L; Li, M; Ruan, Q; Xiao, L; Xie, W; Yao, P; Yu, H; Zhou, X | 1 |
| Chi, Y; Liang, Y; Liu, S; Wang, H; Wang, Y; Wu, X; Zhu, B | 1 |
| Geng, J; Gu, W; Guan, Y; Hou, X; Li, X; Song, G; Wang, C; Wang, X; Yang, L; Zheng, K | 1 |
| El-Sayed, NS; Elatrebi, S; Ibrahim, HF; Omar, EM; Said, R | 1 |
| Du, H; Hou, J; Li, N; Liu, J; Xu, F | 1 |
| Cheng, B; Dong, Y; Guo, R; Jia, K; Jin, P; Pan, Q; Xu, P; Xu, Y; Zhou, M; Zhu, W | 1 |
| Ding, X; Ding, Y; Li, S; Tan, Q; Yang, P; Zhang, H | 1 |
| Akgun-Unal, N; Baltaci, AK; Gulbahce-Mutlu, E; Mogulkoc, R; Ozyildirim, S; Unal, O | 1 |
| Akhtar, MS; Almalki, ZS; Imam, MT; Kumar, A; Mukherjee, M; Sharma, AK; Sharma, G; Tabassum, F | 1 |
| Abed, A; Abu Dayyih, W; Abumansour, H; Aburumman, A; Daoud, E; Hailat, M; Hamad, M; Majeed, B; Majeed, JM; Saadh, MJ; Tamimi, LN; Zakaraya, Z | 1 |
| Hu, Y; Liu, Y; Wang, J; Wang, JC; Xu, JX; Zhang, Q; Zhu, LY | 1 |
| Akgun-Unal, N; Baltaci, AK; Baltaci, SB; Mogulkoc, R; Ozyildirim, S; Unal, O | 1 |
| Elswefy, SE; Hammad, SK; Khalil, SG; Shaheen, MA; Younis, NN | 1 |
| Chen, XH; Ma, XH; Sun, XF; Xiao, K; Zhao, Y; Zhong, Z | 1 |
| Dang, LH; Dao, TP; Do, THT; Ha, PT; Nguyen, TP; Pham, TKT; Tran, NQ | 1 |
| Chen, B; Ding, X; Huang, Y; Lai, Y; Ma, Z; Tan, Q; Wang, X; Youjun, D | 1 |
| Chen, MC; Chen, RJ; Chen, TS; Huang, CY; Lai, CH; Lin, YM; PadmaViswanadha, V; Pai, PY; Shen, CY; Yang, CK | 1 |
| Baldissera, MD; Carmo, GMD; Feksa, LR; Fernandes, LS; Franceschi, ID; Giongo, JL; Kolling, J; Mezzomo, NJ; Nishihira, VSK; Orengo, G; Pinto, CG; Rech, VC; Vaucher, RA; Wannmacher, CMD; Wyse, ATS | 1 |
| Chen, YB; Du, L; Gu, XK; Hao, M; Jiang, YF; Li, CC; Li, XZ; Li, Y; Lu, Q; Wang, B; Wang, J; Wang, L; Yang, H; Yin, XX | 1 |
| Huang, X; Li, M; Liang, Y; Lu, J; Lu, X; Pfaff, DW; Tang, M; Tang, YP; Wang, X; Wang, Z; Xie, W; Yao, P | 1 |
| Bezerra Pontes, EO; Carneiro, EM; Coelho de Souza, AN; D Avila, LSP; de Abreu, ES; de Carvalho, DP; de Oliveira, AC; de Oliveira, KA; Leal Cardoso, JH; Nascimento, JF; Rickli, S; Silveira, LR; Torres Leal, FL; Vasconcelos, RP | 1 |
| Ahmed, AF; Hammad, ASA; Heeba, GH; Taye, A | 1 |
| Chen, X; He, Q; Lang, L; Lee, SC; Wang, P; Wu, Q; Xu, P | 1 |
| Chen, Z; Gong, D; Liu, X; Wang, L; Yang, Y; Zhang, J | 1 |
| Hertig, I; Okulicz, M; Szkudelska, K; Szkudelski, T | 1 |
| Bi, R; Hua, Y; Li, Y; Li, Z | 1 |
| Bagul, PK; Banerjee, SK; Rai, RC | 1 |
| Cui, Y; Gou, X; Li, L; Li, Y; Mi, Y; Ning, J; Qiu, Z; Wang, X | 1 |
| Du, L; He, LL; Li, CC; Li, XZ; Li, Y; Liu, YQ; Lu, Q; Ma, P; Qian, X; Shu, FL; Xu, L; Yin, XX | 1 |
| Bodakhe, SH; Singh, A | 1 |
| Chen, H; Chen, Z; Liu, X; Wang, M; Weng, X | 1 |
| Arruri, V; Gundu, C; Kalvala, AK; Kumar, A; Kumar, R; Sherkhane, B; Yerra, VG | 1 |
| Bozcaarmutlu, A; Bozdoğan, Ö; Ekşioğlu, D; Kaya, ST; Kılınç, L; Kükner, A; Özarslan, OT; Sapmaz, C | 1 |
| Fischer, LW; Mendes, TB; Miraglia, SM; Simas, JN; Vendramini, V | 1 |
| Casati, MZ; Cirano, FR; Corrêa, MG; Molez, AM; Pimentel, SP; Ribeiro, FV; Tenenbaum, HC | 1 |
| Abdel-Bakky, MS; Abo-Saif, AA; Abo-Youssef, AM; Darwish, MA; Messiha, BAS | 2 |
| Deniziak, M; Noskowiak, W; Sassek, M; Szkudelska, K; Szkudelski, I; Szkudelski, T | 1 |
| Cheng, Y; Deng, B; Lin, Q; Liu, X; Yu, H; Zhang, W | 1 |
| Bostancıeri, N; Elbe, H; Eşrefoğlu, M; Vardı, N | 1 |
| Al-Hussaini, H; Kilarkaje, N; Kittaneh, RS | 1 |
| Hacımustafaoğlu, F; Özçelik, F; Tanoğlu, A | 1 |
| Chen, H; Zheng, T | 1 |
| Eroglu, I; Fattal, E; Gokce, EH; Gokce, G; Ozer, O; Tekmen, I; Tsapis, N; Tuncay Tanrıverdi, S | 1 |
| Chen, TY; Cooper, B; Ferruzzi, MG; Ho, L; Janle, EM; Pasinetti, GM; Simon, JE; Talcott, ST; Todd, G; Wang, J; Wu, QL | 1 |
| Abbasi Oshaghi, E; Adeli, K; Goodarzi, MT; Higgins, V | 1 |
| Casarin, RC; Cirano, FR; Corrêa, MG; Pimentel, SP; Pino, DS; Ribeiro, FV | 1 |
| Ding, DF; Dong, CL; Lu, YB; Ma, JH; Pan, ML; Xu, XH; Ye, XL; Yong, HJ; You, N; You, Q | 1 |
| Mendes, TB; Miraglia, SM; Paccola, CC; Simas, JN; Vendramini, V | 1 |
| Chen, T; Huang, W; Liang, G; Qian, J; Sun, C; Wang, J; Xu, Z; Ye, S; You, S; Zhang, H | 1 |
| Ahn, YB; Kim, JW; Kim, MJ; Kim, P; Ko, SH; Lee, EM; Lee, YJ; Park, I; You, YH | 1 |
| Aktaş, Y; Karatoprak, GŞ; Yücel, Ç | 1 |
| Bozdogan, O; Eksioglu, D; Erim, F; Firat, T; Kaya, ST; Ozarslan, TO; Taskin, E; Yasar, S | 1 |
| Akash, MSH; Munawar, SM; Rehman, K; Saeed, K | 1 |
| Chang, J; Du, LL; Fang, Z; Lin, SH; Liu, XM; Yuan, D | 1 |
| Han, P; Li, S; Song, G; Sun, H; Wang, D; Yang, Y; Zou, X | 1 |
| Li, Z; Liu, B; Song, X; Wang, G; Zhao, L | 1 |
| Beraldi, EJ; Borges, SC; Buttow, NC; Ferreira, PEB; Natali, MRM | 1 |
| Chi, Y; Kang, Y; Li, Y; Liu, W; Lu, H; Niu, H; Zhang, T | 1 |
| Chen, M; Diao, J; Fan, G; Lin, L; Wei, J; Yan, R | 1 |
| Higashi, K; Higashi, Y; Ishii, K; Mori, A; Nakahara, T; Sakamoto, K | 1 |
| Huang, J; Li, H; Li, Y; Liang, J; Liang, Q; Lu, Y; Yan, Y; Zhao, L | 1 |
| Erkan, SO; Görgülü, O; Gürgen, SG; Özdaş, T; Pelit, A; Taştekin, B; Tuhanioğlu, B | 1 |
| Kaczmarczyk-Sedlak, I; Mrukwa-Kominek, E; Sedlak, L; Wojnar, W; Wyględowska-Promieńska, D; Zych, M | 1 |
| Bi, F; Chen, Y; Guo, H; Li, H; Liu, S; Liu, W; Meng, J; Tang, K; Wei, H | 1 |
| Cheang, WS; Cheng, CK; Huang, Y; Lau, CW; Ma, RCW; Tian, XY; Wang, L; Wang, N; Wong, WT; Xu, A | 1 |
| Aabdelbaset, M; Ammar, HI; Ashour, H; Fadel, M; Kamar, SS; Rashed, LA; ShamsEldeen, AM; Shoukry, HS | 1 |
| Duruksu, G; Eraldemir, FC; Gocmez, SS; Polat, S; Şahin, TD; Utkan, T; Yazir, Y | 1 |
| Huo, X; Li, C; Meng, Q; You, B; Zhang, T | 1 |
| Chen, BC; Chen, RJ; Chen, TS; Day, CH; Huang, CY; Kuo, CH; Lin, YM; Padma, VV; Pan, LF | 1 |
| Huang, CY; Li, J; Liang, D; Liao, SC; Peng, X; Su, H; Ting, WJ | 1 |
| Dong, Y; Li, F; Peng, G; Qian, C; Wan, G; Yan, P | 1 |
| Alizadeh, Z; Bahmanzadeh, M; Fathi, N; Goodarzi, MT; Rezaei Farimani, A | 1 |
| Hajizadeh-Sharafabad, F; Maleki, V; Sahebkar, A; Zabetian-Targhi, F | 1 |
| Chang, RL; Chen, RJ; Chen, TS; Day, CH; Huang, CY; Ju, DT; Lin, YC; Viswanadha, VP; Yao, CH; Yeh, YL | 1 |
| Ahmad, S; Aktaş, HS; Ayaz-Adakul, B; Canbey-Göret, C; Elcioglu, HK; Kabasakal, L; Kudas, I; Ozel, Y; Pençe, HH; Şekerler, T; Tetik, S | 1 |
| Avitabile, T; Fiedorowicz, M; Figus, M; Nowomiejska, K; Porta, A; Posarelli, C; Reibaldi, M; Rejdak, R; Toro, MD; Tripodi, S | 1 |
| Ahmadieh, H; Mohammad-Nejad, D; Soufi, FG | 1 |
| Chen, JK; Chen, KH; Jing, YH; Kuo, PC; Pao, CC | 1 |
| Akgul, EO; Cayci, T; Gulcan Kurt, Y | 1 |
| Prabhakar, O | 1 |
| He, BL; Shen, LL; Wang, XM | 1 |
| Haidari, F; Mohammadshahi, M; Soufi, FG | 1 |
| Chang, CC; Chang, CY; Huang, JP; Hung, LM; Tsai, YL; Tung, HC; Yang, MH; Yen, TH | 1 |
| Chen, Y; Dai, YT; Qiu, XF; Wan, Z; Yu, W | 1 |
| Carlson, OD; de Cabo, R; Doyle, ME; Egan, JM; Farhang, K; Fiori, JL; Gadkaree, SK; González-Mariscal, I; Kim, W; Krzysik-Walker, SM; Mattison, JA; Moaddel, R; Pearson, KJ; Sanghvi, M; Shin, YK | 1 |
| Aker, F; Ciloglu, NS; Zeytin, K | 1 |
| Chen, J; Gu, Y; Hao, CM; Huang, X; Wen, D; Zhang, L; Zhang, M | 1 |
| Cao, Y; Chang, S; Dong, J; Li, J; Long, R; Zheng, X; Zhou, Y; Zhu, S | 1 |
| Bocchi, L; Bresciani, L; Brighenti, F; Calani, L; Del Rio, D; Delucchi, F; Ray, S; Savi, M; Stilli, D | 1 |
| Lou, XD; Skog, S; Sun, J; Wang, HD; Xia, SJ | 1 |
| Bozan, D; Sadi, G; Yildiz, HB | 1 |
| Ates, B; Elbe, H; Esrefoglu, M; Taskapan, C; Vardi, N; Yologlu, S | 1 |
| Hida, M; Ikeuchi-Takahashi, Y; Kobayashi, T; Matsumoto, T; Onishi, H; Taguchi, K | 1 |
| Bai, WW; Liu, XQ; Lu, XT; Sun, YY; Wang, B; Wang, YB; Xing, YF; Yang, Q; Zhao, YX | 1 |
| Ateş, F; Ciloğlu, NS; Ercan, F; Vardar Aker, F; Zeytin, K | 1 |
| Carolo dos Santos, K; Fernandes Junior, A; Fernandes, AA; Octavio Barbanera, P; Pereira Braga, C; Seiva, FR | 1 |
| Acosta, V; Benech, JC; Bervejillo, V; Da Cuña, M; Damián, JP; Oddone, N; Ramírez, I; Zambrana, A | 1 |
| Ciddi, V; Dodda, D | 1 |
| Cho, SJ; Choi, MS; Jung, UJ; Kim, HJ; Moon, BS; Park, HJ | 1 |
| Achaval, M; Augustin, OA; Baptista, PP; Barbosa, S; Brambilla Bagatini, P; Mestriner, RG; Neves, L; Nunes de Senna, P; Saur, L; Souto, AA; Xavier, LL | 1 |
| Aktug, H; Erbas, O; Oltulu, F; Pala, EE; Pala, HG; Taskiran, D; Yavasoglu, A | 1 |
| Cao, XM; Fan, DS; Wang, LM; Zhang, Y; Zhen, L | 1 |
| Gao, S; Liang, X; Liu, J; Liu, W; Wan, Z; Wu, Y; Yuan, Z; Zhuo, X | 1 |
| Gencoglu, H; Hayirli, A; Sahin, K; Tuzcu, M | 1 |
| Andrews, KL; Berger, PJ; Chin-Dusting, JP; Horlock, D; Jefferis, AM; Joshi, MS; Kaye, DM; Samarasinghe, T; Williams, D | 1 |
| Domínguez-Rodríguez, A; Hmadcha, A; Lachaud, CC; López-Beas, J; Pezzolla, D; Smani, T; Soria, B | 1 |
| Gao, Y; Kang, L; Li, C; Li, Q; Liu, R; Sun, C; Wang, J; Wang, X | 1 |
| Coulson, FR; Fenning, AS; Pullen, C; Vella, RK | 1 |
| Álvarez, C; Cuadrado, A; Fernández-Millán, E; González-Rodríguez, Á; Mas-Gutierrez, JA; Pardo, V; Rada, P; Ros, M; Santamaría, B; Serrano, M; Valverde, ÁM | 1 |
| Du, Q; Jiang, C; Liu, B; Liu, Z; Zhang, J | 1 |
| Baloğlu, MC; Pektaş, MB; Sadi, G | 1 |
| Mashghoolozekr, E; Mozafari, M; Nekooeian, AA; Panjeshahin, MR | 1 |
| Guo, R; Li, W; Liu, B; Liu, W; Xu, Y; Zhang, B | 1 |
| An, R; Bai, Y | 1 |
| Koca, HB; Koca, T; Pektaş, MB; Sadi, G; Tosun, M | 1 |
| Konat, D; Sadi, G | 1 |
| Bilgin, HM; Deniz Obay, B; Elbey, B; Şermet, A; Taşdemir, E; Yazgan, ÜC | 1 |
| Aktaş, A; Atamer, Y; Deveci, E; Ezel, T; Kocyigit, Y; Sermet, A; Uysal, E; Yavuz, D | 1 |
| Elbe, H; Esrefoglu, M; Ozerol, E; Tanbek, K; Taslidere, E; Vardi, N | 1 |
| Bagul, PK; Banerjee, SK; Deepthi, N; Sultana, R | 1 |
| Ceçen, S; Ergin, K; Yaylali, A | 1 |
| Goodarzi, MT; Karimi, J; Khazaei, M; Khodadadi, I; Moridi, H; Saidijam, M; Sheikh, N | 1 |
| Al-Hussaini, H; Faid, I; Kilarkaje, N | 1 |
| Hida, M; Kobayashi, T; Matsumoto, T; Taguchi, K | 1 |
| Koca, HB; Koca, T; Pektaş, MB; Sadi, G; Tosun, M; Vurmaz, A; Yuksel, Y | 1 |
| Chen, JZ; Chen, QH; Kang, LN; Li, GN; Li, R; Wei, ZH; Wu, H; Xie, J; Xu, B | 1 |
| Abourehab, MA; Balata, GF; Essa, EA; Shamardl, HA; Zaidan, SH | 1 |
| Chen, Z; Duan, Z; Fu, R; Gao, J; Han, J; Jia, L; Lu, J; Lv, Z; Ma, L; Tian, L; Wang, L | 1 |
| Huang, Q; Li, H; Shi, JX; Wang, QJ | 1 |
| Huang, Y; Li, M; Liang, X; Shen, Y; Xu, W; Yan, C; You, H | 1 |
| Fenning, AS; Irwin, JC; Phyu, HE; Vella, RK | 1 |
| Bayram, Z; Dalaklioglu, S; Ozdem, S; Tasatargil, A | 1 |
| Huang, F; Li, A; Li, J; Liu, B; Liu, K; Zhang, S | 1 |
| Deng, B; Huang, L; Li, S; Ming, J; Song, Y; Wang, D; Wang, J; Wang, Y; Wu, X; Yang, N; Yang, Y; Yu, X; Zeng, K; Zhou, X | 1 |
| Hussein, MM; Mahfouz, MK | 1 |
| Guan, GJ; Liu, G; Liu, HY; Sun, LN; Wang, XL; Wu, LY; Zhao, L | 1 |
| An, R; Dang, H; Geng, T; Liang, X; Liu, Y; Ren, G; Tian, X; Yin, L | 1 |
| Bagul, PK; Banerjee, SK; Chakravarty, S; Jhelum, P; Kaur, G; Kumar, A; Kumar, KP; Maitra, S; Reddy, BR | 1 |
| Asadi, S; Goodarzi, MT; Khyripour, N; Mahmoodi, M; Moradi, MN | 1 |
| Chen, L; Li, GN; Li, R; Sheng, ZQ; Wang, L; Wu, H; Xie, J; Xu, B | 1 |
| Benvenuti, LA; Cruz, PL; Irigoyen, MC; Mansur, AP; Pacanaro, AP; Roggerio, A; Salemi, VMC; Strunz, CMC | 1 |
| Goodarzi, MT; Hosseini-Zijoud, SS; Karimi, J; Rezaei Farimani, A; Saidijam, M; Yadegarazari, R; Zarei, S | 1 |
| Tian, Z; Wang, J; Wang, Y; Xu, M; Zhang, M; Zhou, Y | 1 |
| Palsamy, P; Subramanian, S | 3 |
| Corrêa, Mde C; Girotto, E; Gutierres, J; Maldonado, PA; Mazzanti, CM; Moretto, MB; Morsch, VM; Schetinger, MR; Schmatz, R; Spanevello, RM; Stefanello, N | 1 |
| Komuro, I; Minamino, T; Miyauchi, H; Moriya, J; Okada, S; Orimo, M; Tateno, K | 1 |
| Chitolina Schetinger, MR; Corrêa, M; da Rosa, MM; Gutierres, J; Mazzanti, CM; Morsch, VM; Rubin, MA; Schmatz, R; Spanevello, R; Stefanello, N | 1 |
| Abraham, NG; Drummond, G; Falck, JR; Peterson, SJ; Rezzani, R; Rodella, LF; Vanella, L | 1 |
| Cui, J; Gan, L; Hashimoto, T; Ichiki, T; Matsuura, H; Miyazaki, R; Sunagawa, K; Takeda, K; Yin, X | 1 |
| Ungvari, Z; Zhang, C; Zhang, H; Zhang, J | 1 |
| Hueckstaedt, LK; Li, Q; Ren, J | 1 |
| Li, J; Li, Q; Ren, J | 1 |
| Alp, E; Helvacioglu, F; Menevse, S; Take, G; Yar, AS | 1 |
| Bagatini, M; Becker, L; Corrêa, M; da Rosa, CS; Gonçalves, JF; Gutierres, J; Jaques, Jdos S; Maldonado, PA; Mazzanti, CM; Morsch, VM; Schetinger, MR; Schmatz, R; Spanevello, R; Stefanello, N | 1 |
| Gupta, M; Gupta, MP; Matta, MJ; Periasamy, M; Sulaiman, M; Sunderesan, NR | 1 |
| Baluchnejadmojarad, T; Roghani, M | 1 |
| Palsamy, P; Sivakumar, S; Subramanian, S | 1 |
| Cho, GJ; Choi, WS; Kang, SS; Kim, YH; Kim, YS | 1 |
| Chen, JK; Chen, KH; Jing, YH; Kuo, PC; Yang, SH | 1 |
| Akar, F; Gokalp, B; Ozturk, K; Pektas, MB; Sepici, A; Soylemez, S; Surucu, HS; Tufan, C; Ulus, AT | 1 |
| Chang, CC; Day, YJ; Deng, JY; Huang, JP; Huang, SS; Hung, LM | 1 |
| Csiszar, A; Ungvari, Z | 1 |
| He, X; Jia, H; Li, W; Shi, W; Zhong, B | 1 |
| Resmi, H | 1 |
| Fukuhara, S; Miyagawa, Y; Nonomura, N; Okuda, H; Okuyama, A; Takao, T; Tsujimura, A; Yamamoto, K | 1 |
| Chen, JK; Chen, KH; Hsu, HH; Hung, CC; Jing, YH; Yang, CW | 1 |
| Arrick, DM; Mayhan, WG; Patel, KP; Sun, H | 1 |
| Chang, CC; Chang, CY; Huang, JP; Hung, LM; Wu, YT; Yen, TH | 1 |
| Asmis, R; Ullevig, SL; Zamora, D; Zhao, Q | 1 |
| Chen, JK; Chen, KH; Cheng, ML; Chiu, DT; Jing, YH; Shiao, MS | 1 |
| Abdalla, FH; Bagatini, M; Cardoso, AM; Daci da Silva Serres, J; Gutierres, J; Martins, CC; Mazzanti, C; Morsch, VM; Perreira, LB; Schetinger, MR; Schmatz, R; Spanevello, R; Stefanello, N; Vieira, JM; Zanini, D | 1 |
| Cho, GJ; Choi, WS; Kim, YH; Kim, YS; Roh, GS | 1 |
| Ishida, S; Kubota, S; Kurihara, T; Miyake, S; Noda, K; Ozawa, Y; Sasaki, M; Tsubota, K; Yuki, K | 1 |
| He, XH; Jia, HY; Li, W; Shi, WG; Zhong, BH | 1 |
| Alp, E; Menevse, S; Yar, AS | 1 |
| Alp, E; Aricioglu, A; Cumaoglu, A; Dogan, I; Ekmekci, A; Ergin, V; Menevse, A; Menevse, S; Yar, AS | 1 |
| Tuncay, E; Turan, B; Vassort, G | 1 |
| Alipour, MR; Khalili, M; Sheervalilou, R; Soufi, FG; Vardiani, M | 1 |
| Akude, E; Calcutt, NA; Fernyhough, P; Gomes, S; Marquez, A; Morrow, D; Roy Chowdhury, SK; Saleh, A; Schapansky, J; Smith, DR | 1 |
| Manikandan, B; Marimuthu Prabhu, N; Munusamy, A; Palanisamy, S; Priyadarsini, A; Raman, T; Ramar, M; Vaseeharan, B; Velayudam, M | 1 |
| Badary, O; Hamadi, N; Hassan, MH; Khalifi-Touhami, F; Mansour, A | 1 |
| Bagatini, M; Cardoso, AM; Gutierres, J; Leal, CA; Machado, MM; Mann, TR; Martins, CC; Mazzanti, C; Morsch, VM; Pereira, LB; Pimentel, VC; Schetinger, MR; Schmatz, R; Spanevello, R; Stefanello, N; Zanini, D | 1 |
| Mohammadi, M; Sheervalilou, R; Somi, MH; Soufi, FG; Vardyani, M | 1 |
| Anjaneyulu, M; Chopra, K; Kulkarni, SK; Sharma, S | 1 |
| Chen, JK; Hung, LM; Su, HC | 1 |
| Bolego, C; Cignarella, A; Gaion, RM; Minici, C; Pinna, C; Puglisi, L; Sanvito, P | 1 |
| Chopra, K; Kulkarni, SK; Sharma, S | 3 |
| Cohen, RA; Hou, X; Jiang, B; Maitland-Toolan, KA; Verbeuren, TJ; Wierzbicki, M; Xu, S; Zang, M; Zuccollo, A | 1 |
| Altinoz, E; Ates, O; Cayli, SR; Durak, MA; Kocak, A; Turkoz, Y; Yologlu, S; Yucel, N | 1 |
| Iyer, S; Kaundal, RK; Kumar, A; Sharma, SS | 1 |
| Chen, WP; Cheng, JT; Chi, TC; Chi, TL; Kuo, TF; Lee, SS; Su, MJ | 1 |
| Chen, WP; Chi, TC; Chuang, LM; Su, MJ | 1 |
| Bagchi, D; Das, DK; Juhasz, B; Koneru, S; Maulik, N; Otani, H; Penumathsa, SV; Thirunavukkarasu, M; Zhan, L | 1 |
| Aribal-Kocatürk, P; Büyükkağnici, DI; Kavas, GO | 2 |
| Bagchi, D; Maulik, G; Maulik, N; Menon, VP; Penumathsa, SV; Thirunavukkarasu, M; Zhan, L | 1 |
| Gaikwad, A; Kabra, D; Sharma, V; Singh, K; Tikoo, K | 1 |
| Silan, C | 1 |
5 review(s) available for resveratrol and Alloxan Diabetes
| Article | Year |
|---|---|
Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Mice; Resveratrol; Signal Transduction; Stilbenes | 2017 |
The impact of resveratrol on toxicity and related complications of advanced glycation end products: A systematic review.
Topics: Animals; Antigens, Neoplasm; Antioxidants; Atherosclerosis; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Inflammation; Mitogen-Activated Protein Kinases; NF-kappa B; Oxidative Stress; PPAR gamma; Pyruvaldehyde; Resveratrol; Signal Transduction; Transforming Growth Factor beta1 | 2019 |
Effect of Resveratrol on In Vitro and In Vivo Models of Diabetic Retinophathy: A Systematic Review.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans; Mice; Resveratrol | 2019 |
[Advance of resveratrol in treating diabetes mellitus].
Topics: Animals; Diabetes Mellitus, Experimental; Insulin Resistance; Resveratrol; Stilbenes | 2013 |
Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Gene Expression Regulation, Enzymologic; Humans; MAP Kinase Signaling System; Muscle Proteins; Myocardium; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Resveratrol; Sirtuin 1; Stilbenes | 2012 |
201 other study(ies) available for resveratrol and Alloxan Diabetes
| Article | Year |
|---|---|
Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme Activators; Hypoglycemic Agents; Imidazoles; Mice; Quinoxalines; Rats; Rats, Zucker; Sirtuin 1; Structure-Activity Relationship; Thiazoles | 2009 |
trans-Resveratrol in Gnetum gnemon protects against oxidative-stress-induced endothelial senescence.
Topics: Adult; Animals; Benzofurans; Cellular Senescence; Diabetes Mellitus, Experimental; Gnetum; Humans; Hydrogen Peroxide; Indonesia; Mice; Molecular Structure; Nitric Oxide Synthase Type III; Oxidative Stress; Resveratrol; Seeds; Sirtuin 1; Stereoisomerism; Stilbenes; Umbilical Veins | 2013 |
Resveratrol inhibits neural apoptosis and regulates RAX/P-PKR expression in retina of diabetic rats.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Rats; Rats, Sprague-Dawley; Resveratrol; Retina | 2022 |
Topical administration of pterostilbene accelerates burn wound healing in diabetes through activation of the HIF1α signaling pathway.
Topics: Administration, Topical; Animals; Burns; Diabetes Mellitus, Experimental; Human Umbilical Vein Endothelial Cells; Humans; Rats; Resveratrol; Signal Transduction; Stilbenes; Wound Healing | 2022 |
Knowledge-Based Discovery of the Role and Mechanism of Resveratrol in Improving Glomerular Tether Cell Proliferation and Apoptosis in Diabetic Nephropathy.
Topics: Animals; Apoptosis; Cell Proliferation; Cross-Sectional Studies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Knowledge Discovery; Resveratrol; Streptozocin | 2022 |
Pterostilbene, a Resveratrol Derivative, Improves Ectopic Lipid Deposition in the Kidneys of Mice Induced by a High-Fat Diet.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Fibrosis; Kidney; Lipids; Mice; Resveratrol; Stilbenes; Transforming Growth Factor beta1 | 2022 |
Potential mechanisms underlying the association between type II diabetes mellitus and cognitive dysfunction in rats: a link between miRNA-21 and Resveratrol's neuroprotective action.
Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Insulin; Lipids; MicroRNAs; Rats; Resveratrol; Streptozocin | 2022 |
Anti-inflammation properties of resveratrol in the detrusor smooth muscle of the diabetic rat.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Diabetes Mellitus, Experimental; Excipients; Glucose; Inflammation; Interleukin-6; Muscle, Smooth; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Streptozocin; Tumor Necrosis Factor-alpha | 2022 |
A composite hydrogel containing resveratrol-laden nanoparticles and platelet-derived extracellular vesicles promotes wound healing in diabetic mice.
Topics: Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Experimental; Extracellular Vesicles; Gelatin; Human Umbilical Vein Endothelial Cells; Humans; Hydrogels; Mice; Resveratrol; Wound Healing | 2022 |
Resveratrol accelerates wound healing by inducing M2 macrophage polarisation in diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Humans; Macrophages; Mice; Resveratrol; Tumor Necrosis Factor-alpha; Wound Healing | 2022 |
The effects of resveratrol and melatonin on biochemical and molecular parameters in diabetic old female rat hearts.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Melatonin; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Wistar; Resveratrol; Sirtuin 1; Streptozocin | 2023 |
Preliminary investigation on impact of intergenerational treatment of resveratrol endorses the development of 'super-pups'.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Glutathione; Oxidative Stress; Rats; Resveratrol; Stilbenes | 2023 |
Anti-diabetic effect of cotreatment with resveratrol and pioglitazone in diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin Resistance; Lipids; Oxidative Stress; Pioglitazone; Rats; Rats, Sprague-Dawley; Resveratrol | 2023 |
Resveratrol improves diabetes-induced cognitive dysfunction in part through the miR-146a-5p/TXNIP axis.
Topics: Animals; Cell Cycle Proteins; Cognitive Dysfunction; Diabetes Mellitus, Experimental; MicroRNAs; Rats; Resveratrol; Tumor Necrosis Factor-alpha | 2023 |
The effects of resveratrol and melatonin on cardiac dysfunction in diabetic elderly female rats.
Topics: Animals; Diabetes Mellitus, Experimental; Female; Heart Diseases; Melatonin; Papillary Muscles; Rats; Resveratrol | 2023 |
Evaluation of in vivo and ex vivo pre-treated bone marrow-derived mesenchymal stem cells with resveratrol in streptozotocin-induced type 1 diabetic rats.
Topics: Animals; Bone Marrow; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Insulin; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Resveratrol; Streptozocin | 2023 |
Low-Dose Trans-Resveratrol Ameliorates Diabetes-Induced Retinal Ganglion Cell Degeneration via TyrRS/c-Jun Pathway.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; HEK293 Cells; Humans; Mice; Resveratrol; Retina; Retinal Ganglion Cells | 2023 |
Injectable thermogel incorporating reactive oxygen species scavenger and nitric oxide donor to accelerate the healing process of diabetic wounds.
Topics: Animals; Anti-Bacterial Agents; Arginine; Diabetes Mellitus, Experimental; Fishes; Hydrogels; Mice; Nitric Oxide Donors; Reactive Oxygen Species; Resveratrol | 2023 |
Mechanisms of resveratrol against diabetic wound by network pharmacology and experimental validation.
Topics: Animals; Cytokines; Diabetes Mellitus, Experimental; Humans; Mice; Network Pharmacology; Phosphatidylinositol 3-Kinases; Resveratrol | 2023 |
Orally administered resveratrol enhances the therapeutic effect of autologous transplanted adipose-derived stem cells on rats with diabetic hepatopathy.
Topics: Adipose Tissue; Administration, Oral; Animals; Antioxidants; Diabetes Mellitus, Experimental; Liver; Liver Diseases; Male; Rats; Rats, Wistar; Resveratrol; Stem Cell Transplantation; Stem Cells; Thiobarbituric Acid Reactive Substances | 2020 |
Resveratrol and resveratrol-hydroxypropyl-β-cyclodextrin complex recovered the changes of creatine kinase and Na+, K+-ATPase activities found in the spleen from streptozotocin-induced diabetic rats.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antioxidants; Blood Glucose; Body Weight; Creatine Kinase; Diabetes Mellitus, Experimental; Energy Metabolism; Hyperglycemia; Male; Organ Size; Rats; Rats, Wistar; Resveratrol; Sodium-Potassium-Exchanging ATPase; Spleen; Streptozocin | 2019 |
A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Kelch-Like ECH-Associated Protein 1; Ketones; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Morpholines; NF-E2-Related Factor 2; Oxidative Stress; Resveratrol; Signal Transduction; Structure-Activity Relationship | 2020 |
Maternal diabetes induces autism-like behavior by hyperglycemia-mediated persistent oxidative stress and suppression of superoxide dismutase 2.
Topics: Amygdala; Animals; Autistic Disorder; Blood-Brain Barrier; Diabetes Mellitus, Experimental; Diabetes, Gestational; Early Growth Response Protein 1; Female; Gene Knockdown Techniques; Histones; Hyperglycemia; Methylation; Oxidative Stress; Pregnancy; Promoter Regions, Genetic; Rats; Reactive Oxygen Species; Resveratrol; Superoxide Dismutase | 2019 |
Hypoglycaemic effect of resveratrol in streptozotocin-induced diabetic rats is impaired when supplemented in association with leucine.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, White; Adiposity; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Dietary Supplements; Drug Interactions; Fruit; Hypoglycemic Agents; Insulin; Insulin Resistance; Leucine; Male; Phytotherapy; Rats; Resveratrol | 2020 |
Heme oxygenase-1 contributes to the protective effect of resveratrol against endothelial dysfunction in STZ-induced diabetes in rats.
Topics: Animals; Antioxidants; Aorta; Diabetes Mellitus, Experimental; Endothelial Cells; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Male; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Resveratrol; Streptozocin | 2019 |
Resveratrol attenuates diabetes-associated cell centrosome amplification via inhibiting the PKCα-p38 to c-myc/c-jun pathway.
Topics: Animals; Centrosome; Colon; Diabetes Mellitus, Experimental; Gene Knockdown Techniques; Glucose; HCT116 Cells; Humans; Insulin; Mice; p38 Mitogen-Activated Protein Kinases; Palmitic Acid; Phosphorylation; Protein Kinase C-alpha; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; Resveratrol; RNA, Small Interfering; Signal Transduction; Streptozocin; Transfection | 2020 |
Inhibition of the SIRT1 signaling pathway exacerbates endoplasmic reticulum stress induced by renal ischemia/reperfusion injury in type 1 diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endoplasmic Reticulum Stress; Kidney; Kidney Function Tests; Male; Pyroptosis; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Signal Transduction; Sirtuin 1 | 2020 |
Resveratrol ameliorates inflammatory and oxidative stress in type 2 diabetic Goto-Kakizaki rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Inflammation Mediators; Lipid Peroxidation; Liver; Oxidative Stress; Rats; Resveratrol | 2020 |
Resveratrol treatment promotes titanium implant osseointegration in diabetes mellitus rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Male; Osseointegration; Rats, Sprague-Dawley; Resveratrol; X-Ray Microtomography | 2020 |
NLRP3 inflammasome drives inflammation in high fructose fed diabetic rat liver: Effect of resveratrol and metformin.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fructose; Hypoglycemic Agents; Inflammasomes; Inflammation; Insulin Resistance; Liver; Male; Metformin; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Resveratrol | 2020 |
Resveratrol alleviates diabetic mechanical allodynia in rats by downregulating P2X3R.
Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Down-Regulation; Drug Administration Routes; Ganglia, Spinal; Hyperalgesia; Male; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X3; Resveratrol; Spinal Cord Dorsal Horn; Stomach; Streptozocin | 2020 |
Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial-Mesenchymal Transition; Fibrosis; Gene Knockdown Techniques; Glucose; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mice; Resveratrol; Sirtuin 1; YY1 Transcription Factor | 2021 |
Biochemical Evidence Indicates the Preventive Effect of Resveratrol and Nicotinamide in the Treatment of STZ-induced Diabetic Cataract.
Topics: Aldehyde Reductase; Animals; Antioxidants; Blood Glucose; Cataract; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Hyperglycemia; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Niacinamide; Oxidative Stress; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Resveratrol; Sodium-Potassium-Exchanging ATPase; Sorbitol; Streptozocin; Vitamin B Complex | 2021 |
Resveratrol inhibits TNF-α-induced inflammation to protect against renal ischemia/reperfusion injury in diabetic rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Inflammation; Kidney; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Tumor Necrosis Factor-alpha | 2020 |
Chronic hyperglycemia impairs mitochondrial unfolded protein response and precipitates proteotoxicity in experimental diabetic neuropathy: focus on LonP1 mediated mitochondrial regulation.
Topics: Animals; ATP-Dependent Proteases; Chronic Disease; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Heat-Shock Proteins; Hyperglycemia; Male; Mitochondria; Mitochondrial Proteins; PC12 Cells; Rats; Rats, Sprague-Dawley; Resveratrol; Unfolded Protein Response | 2020 |
The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver.
Topics: Animals; Antioxidants; Berberine; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2B1; Diabetes Mellitus, Experimental; Dimethyl Sulfoxide; Glyburide; Liver; Rats; Rats, Wistar; Resveratrol; Xenobiotics | 2022 |
Resveratrol improves sperm DNA quality and reproductive capacity in type 1 diabetes.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; DNA Fragmentation; Drug Evaluation, Preclinical; Infertility, Male; Lipid Peroxidation; Male; Rats, Wistar; Reproduction; Resveratrol; Spermatozoa | 2021 |
Resveratrol and insulin association reduced alveolar bone loss and produced an antioxidant effect in diabetic rats.
Topics: Alveolar Bone Loss; Animals; Antioxidants; Diabetes Mellitus, Experimental; Insulin; Male; Rats; Rats, Wistar; Resveratrol | 2021 |
Resveratrol inhibits macrophage infiltration of pancreatic islets in streptozotocin-induced type 1 diabetic mice via attenuation of the CXCL16/NF-κΒ p65 signaling pathway.
Topics: Animals; Chemokine CXCL16; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Islets of Langerhans; Macrophages; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Resveratrol; Signal Transduction; Streptozocin; Transcription Factor RelA | 2021 |
Resveratrol Affects Insulin Signaling in Type 2 Diabetic Goto-Kakizaki Rats.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin; Male; Phosphorylation; Rats; Receptor, Insulin; Resveratrol; Signal Transduction | 2021 |
Anti-inflammatory effect of resveratrol attenuates the severity of diabetic neuropathy by activating the Nrf2 pathway.
Topics: Animals; Antioxidants; Behavior, Animal; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Mice; Mice, Knockout; NF-E2-Related Factor 2; Resveratrol; Signal Transduction | 2021 |
Resveratrol mitigates pancreatic TF activation and autophagy-mediated beta cell death via inhibition of CXCL16/ox-LDL pathway: A novel protective mechanism against type 1 diabetes mellitus in mice.
Topics: Animals; Antioxidants; Autophagy; Cell Death; Chemokine CXCL16; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose Tolerance Test; Insulin-Secreting Cells; Lipoproteins, LDL; Male; Mice; Mice, Inbred BALB C; Protective Agents; Resveratrol; Signal Transduction; Thromboplastin | 2021 |
Cardioprotective potential of melatonin, quercetin and resveratrol in an experimental model of diabetes.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Melatonin; Models, Theoretical; Oxidative Stress; Quercetin; Rats; Rats, Wistar; Resveratrol | 2022 |
Effects of trans-resveratrol on type 1 diabetes-induced up-regulation of apoptosis and mitogen-activated protein kinase signaling in retinal pigment epithelium of Dark Agouti rats.
Topics: Aldehydes; Animals; Antigens, Bacterial; Apoptosis; Bacterial Toxins; Blood Glucose; Body Weight; Caspase 3; Caspase 8; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Rats; Resveratrol; Retinal Pigment Epithelium; Streptozocin; Up-Regulation | 2021 |
Modulatory effect of resveratrol and melatonin on natural killer cell activity and adrenomedullin in diabetic rats.
Topics: Adrenomedullin; Animals; Antioxidants; Biomarkers; Diabetes Mellitus, Experimental; Interleukin-6; Killer Cells, Natural; Melatonin; Oxidants; Rats; Rats, Sprague-Dawley; Resveratrol; Tumor Necrosis Factor-alpha | 2022 |
Resveratrol ameliorates the glucose uptake and lipid metabolism in gestational diabetes mellitus mice and insulin-resistant adipocytes via miR-23a-3p/NOV axis.
Topics: Adipocytes; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes, Gestational; Diet, High-Fat; Disease Models, Animal; Female; Glucose; Insulin; Insulin Resistance; Lipid Metabolism; Mice; MicroRNAs; Nephroblastoma Overexpressed Protein; Pregnancy; Proto-Oncogene Proteins c-akt; Resveratrol; Wilms Tumor | 2021 |
Wound healing effects of collagen-laminin dermal matrix impregnated with resveratrol loaded hyaluronic acid-DPPC microparticles in diabetic rats.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Cutaneous; Animals; Cattle; Collagen; Diabetes Mellitus, Experimental; Drug Carriers; Hyaluronic Acid; Laminin; Male; Microspheres; Rats; Rats, Wistar; Resveratrol; Skin; Stilbenes; Treatment Outcome; Wound Healing | 2017 |
Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.
Topics: Animals; Anthocyanins; Biological Availability; Blood Glucose; Brain; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonoids; Grape Seed Extract; Male; Polyphenols; Quercetin; Rats; Rats, Zucker; Resveratrol; Stilbenes; Tandem Mass Spectrometry; Vitis | 2017 |
Effect of Resveratrol on Critical-Sized Calvarial Defects of Diabetic Rats: Histometric and Gene Expression Analysis.
Topics: Animals; Biomarkers; Bone Density Conservation Agents; Bone Regeneration; Diabetes Mellitus, Experimental; Gene Expression Regulation; Insulin; Male; Rats; Rats, Wistar; Resveratrol; Skull; Stilbenes; Streptozocin; Wound Healing | 2017 |
Resveratrol transcriptionally regulates miRNA-18a-5p expression ameliorating diabetic nephropathy via increasing autophagy.
Topics: Adenine; Animals; Ataxia Telangiectasia Mutated Proteins; Autophagy; Caspase 3; Cell Line; Creatinine; Diabetes Mellitus, Experimental; Down-Regulation; Male; Mice; Mice, Obese; MicroRNAs; Microtubule-Associated Proteins; Resveratrol; RNA Interference; RNA, Small Interfering; Sirolimus; Stilbenes; Up-Regulation | 2017 |
Resveratrol attenuates reproductive alterations in type 1 diabetes-induced rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Epididymis; Male; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Reproduction; Resveratrol; Sperm Motility; Spermatozoa; Stilbenes; Testis | 2017 |
An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Cardiovascular Agents; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gene Expression Regulation; Glucose; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Resveratrol; Signal Transduction; Streptozocin | 2018 |
Effect of resveratrol treatment on graft revascularization after islet transplantation in streptozotocin-induced diabetic mice.
Topics: Animals; Cells, Cultured; Chemotherapy, Adjuvant; Combined Modality Therapy; Diabetes Mellitus, Experimental; Graft Survival; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Neovascularization, Physiologic; Resveratrol; Streptozocin | 2018 |
Nanoliposomal Resveratrol as a Novel Approach to Treatment of Diabetes Mellitus.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Drug Delivery Systems; Insulin; Liposomes; Nanoparticles; Oxidative Stress; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2018 |
The protection of resveratrol and its combination with glibenclamide, but not berberine on the diabetic hearts against reperfusion-induced arrhythmias: the role of myocardial K
Topics: Animals; Arrhythmias, Cardiac; Berberine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Interactions; Glyburide; Heart; Hemodynamics; Male; Myocardial Reperfusion Injury; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Resveratrol | 2019 |
Resveratrol regulates hyperglycemia-induced modulations in experimental diabetic animal model.
Topics: Animals; Antioxidants; Blood Glucose; Calcium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Hyperglycemia; Insulin; Insulin Resistance; Magnesium; Male; Metformin; Rats; Resveratrol; Stilbenes; Vitamin E | 2018 |
Protective effect of resveratrol on kidney in rats with diabetic nephropathy and its effect on endoplasmic reticulum stress.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Kidney; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Streptozocin | 2018 |
Resveratrol Improves Muscle Atrophy by Modulating Mitochondrial Quality Control in STZ-Induced Diabetic Mice.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Biomarkers; Diabetes Mellitus, Experimental; Dietary Supplements; Gene Expression Regulation; Male; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Mitochondria, Muscle; Mitochondrial Dynamics; Muscle Proteins; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Muscular Disorders, Atrophic; Resveratrol; Signal Transduction; Streptozocin; Tripartite Motif Proteins; Ubiquitin; Ubiquitin-Protein Ligases | 2018 |
Resveratrol Prevents Diabetic Cardiomyopathy by Increasing Nrf2 Expression and Transcriptional Activity.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Gene Expression Regulation; Male; Mice; NF-E2-Related Factor 2; Resveratrol; Stilbenes; Transcription, Genetic | 2018 |
Resveratrol promotes neuroprotection and attenuates oxidative and nitrosative stress in the small intestine in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Intestine, Small; Male; Myenteric Plexus; Neuroprotective Agents; Nitrosative Stress; Oxidative Stress; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2018 |
Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1/PGC-1α mediated attenuation of mitochondrial oxidative stress.
Topics: Animals; Apoptosis; Cell Line; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose; Male; Malondialdehyde; Membrane Potential, Mitochondrial; Mice; Mitochondria; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Podocytes; Proteinuria; Reactive Oxygen Species; Resveratrol; Sirtuin 1 | 2019 |
Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Line; Cholesterol, LDL; Cytochromes c; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diet, High-Fat; Gene Expression Regulation; Glucose; Insulin Resistance; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Streptozocin; Triglycerides; Uncoupling Protein 2 | 2019 |
Anti-cataract Effect of Resveratrol in High-Glucose-Treated Streptozotocin-Induced Diabetic Rats.
Topics: Aldehyde Reductase; Animals; Antioxidants; Blood Glucose; Cataract; Crystallins; Diabetes Complications; Diabetes Mellitus, Experimental; Dietary Supplements; Glucose; Hyperglycemia; Lens, Crystalline; Male; Oxidative Stress; Phytotherapy; Plant Extracts; Protein Carbonylation; Rats, Wistar; Resveratrol; Sorbitol | 2018 |
Preventative effects of resveratrol and estradiol on streptozotocin-induced diabetes in ovariectomized mice and the related mechanisms.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Estradiol; Extracellular Signal-Regulated MAP Kinases; Fasting; Female; Gene Expression Regulation; Glucose Transporter Type 4; Insulin; Insulin Receptor Substrate Proteins; Islets of Langerhans; Malondialdehyde; Mice; Ovariectomy; Phosphoproteins; Resveratrol | 2018 |
The effect of resveratrol on the histologic characteristics of the cochlea in diabetic rats.
Topics: Animals; Apoptosis; Cochlea; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Immunohistochemistry; In Situ Nick-End Labeling; Male; Otoacoustic Emissions, Spontaneous; Rats; Rats, Wistar; Resveratrol | 2019 |
Effect of Resveratrol, a Dietary-Derived Polyphenol, on the Oxidative Stress and Polyol Pathway in the Lens of Rats with Streptozotocin-Induced Diabetes.
Topics: Animals; Antioxidants; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Diet; Glutathione; Glutathione Peroxidase; Lens, Crystalline; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Phytotherapy; Plant Extracts; Polymers; Polyphenols; Rats, Wistar; Resveratrol; Superoxide Dismutase | 2018 |
Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1.
Topics: Animals; Antioxidants; Aryldialkylphosphatase; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Inflammation; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Retina; RNA | 2019 |
Resveratrol ameliorates endothelial dysfunction in diabetic and obese mice through sirtuin 1 and peroxisome proliferator-activated receptor δ.
Topics: Animals; Diabetes Mellitus, Experimental; Endothelial Cells; Endothelium, Vascular; Humans; Male; Mice, Inbred C57BL; Mice, Transgenic; Obesity; PPAR delta; Resveratrol; Sirtuin 1 | 2019 |
Combined treatment with systemic resveratrol and resveratrol preconditioned mesenchymal stem cells, maximizes antifibrotic action in diabetic cardiomyopathy.
Topics: Animals; Antioxidants; Bone Malalignment; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Random Allocation; Rats; Rats, Wistar; Resveratrol | 2019 |
Resveratrol prevents cognitive deficits by attenuating oxidative damage and inflammation in rat model of streptozotocin diabetes induced vascular dementia.
Topics: Animals; Antioxidants; Avoidance Learning; Brain Chemistry; Cognitive Dysfunction; Cytokines; Dementia, Vascular; Diabetes Mellitus, Experimental; Encephalitis; Endothelium, Vascular; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Resveratrol | 2019 |
Resveratrol Effects on a Diabetic Rat Model with Coronary Heart Disease.
Topics: Animals; Blotting, Western; China; Cholesterol; Coronary Disease; Diabetes Mellitus, Experimental; Disease Models, Animal; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Insulin; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; Male; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2019 |
Resveratrol increases stem cell function in the treatment of damaged pancreas.
Topics: Adipocytes; Adipose Tissue; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Neovascularization, Physiologic; Pancreas; Rats, Wistar; Resveratrol; Stem Cells | 2019 |
Ramipril and resveratrol co-treatment attenuates RhoA/ROCK pathway-regulated early-stage diabetic nephropathy-associated glomerulosclerosis in streptozotocin-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Kidney; Male; Ramipril; Rats; Rats, Sprague-Dawley; Resveratrol; rho-Associated Kinases; rhoA GTP-Binding Protein; Severity of Illness Index; Signal Transduction; Streptozocin | 2019 |
Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Eye Proteins; Gold; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Male; Metal Nanoparticles; Mitogen-Activated Protein Kinase 3; Nerve Growth Factors; NF-kappa B; Rats; Rats, Wistar; Resveratrol; Retina; Serpins; Signal Transduction; Streptozocin; Vascular Endothelial Growth Factor A | 2019 |
Resveratrol supplementation improves DNA integrity and sperm parameters in streptozotocin-nicotinamide-induced type 2 diabetic rats.
Topics: Animals; Antioxidants; Chromatin; Chromatin Assembly and Disassembly; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Humans; Infertility, Male; Male; Niacinamide; Rats; Rats, Wistar; Resveratrol; Sperm Count; Sperm Motility; Spermatozoa; Streptozocin; Treatment Outcome | 2019 |
Protective effect of autologous transplantation of resveratrol preconditioned adipose-derived stem cells in the treatment of diabetic liver dysfunction in rat model.
Topics: Adipose Tissue; Animals; Apoptosis; Cell Survival; Clone Cells; Culture Media, Conditioned; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose; Liver; Liver Cirrhosis; Liver Diseases; Male; Protective Agents; Rats, Wistar; Resveratrol; Signal Transduction; Sirtuin 1; Stem Cell Transplantation; Stem Cells; Tissue Survival; Transplantation, Autologous | 2019 |
Protective effects of resveratrol on hepatic ischemia reperfusion injury in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Glutathione; Liver; Malondialdehyde; Protective Agents; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Streptozocin; Tumor Necrosis Factor-alpha | 2019 |
Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor κB - apoptosis pathway.
Topics: Administration, Oral; Animals; Antioxidants; Apoptosis; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glutathione; Glycated Hemoglobin; Insulin; Lipid Peroxidation; Male; NF-kappa B; Niacinamide; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Retina; Signal Transduction; Stilbenes; Streptozocin; Superoxide Dismutase; Time Factors | 2012 |
Neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol.
Topics: Animals; Antioxidants; Astrocytes; Blood-Brain Barrier; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Hippocampus; Male; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin | 2013 |
Two-dimensional evaluations for mitochondrial number are not reliable. Re: 'neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol' by Jing et al.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Male; Nerve Degeneration; Resveratrol; Stilbenes | 2013 |
Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Catalase; Cerebral Infarction; Cytokines; Diabetes Mellitus, Experimental; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase | 2013 |
Chronic resveratrol administration improves diabetic cardiomyopathy in part by reducing oxidative stress.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Dose-Response Relationship, Drug; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Ribonucleotide Reductases; Stilbenes | 2014 |
Resveratrol exhibits differential protective effects on fast- and slow-twitch muscles in streptozotocin-induced diabetic rats.
Topics: Acetyl-CoA Carboxylase; Animals; Antioxidants; Blood Glucose; Blotting, Western; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3; Insulin; Male; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Long-Evans; Resveratrol; Signal Transduction; Stilbenes; Superoxide Dismutase; Superoxides; Triglycerides | 2014 |
Resveratrol, an activator of SIRT1, restores erectile function in streptozotocin-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Down-Regulation; Erectile Dysfunction; Forkhead Box Protein O3; Forkhead Transcription Factors; Male; Penile Erection; Penis; Rats; Resveratrol; Sirtuin 1; Stilbenes; Streptozocin; Tumor Suppressor Protein p53 | 2013 |
Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.
Topics: Animals; Blood Glucose; Body Weight; Cell Dedifferentiation; Densitometry; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Fluorescent Antibody Technique; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Glycated Hemoglobin; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Macaca mulatta; Nuclear Proteins; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors | 2013 |
The effects of resveratrol on flap survival in diabetic rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Ischemia; Necrosis; Oxidative Stress; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Surgical Flaps; Wound Healing | 2014 |
Resveratrol attenuates diabetic nephropathy via modulating angiogenesis.
Topics: Angiogenesis Modulating Agents; Angiopoietin-2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; Mice; Rats; Rats, Sprague-Dawley; Receptor, TIE-2; Resveratrol; Sirtuin 1; Stilbenes; Vascular Endothelial Growth Factor A | 2013 |
Protective effects of chronic resveratrol treatment on vascular inflammatory injury in steptozotocin-induced type 2 diabetic rats: role of NF-kappa B signaling.
Topics: Animals; Aorta, Thoracic; Capillary Permeability; Carotid Arteries; Carotid Artery Injuries; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Endothelial Cells; Humans; Hypoglycemic Agents; Insulin; Interleukin-1beta; Interleukin-6; Lipids; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2013 |
Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats.
Topics: Animals; Biotransformation; Blood Glucose; Body Weight; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Glucuronides; Heart Diseases; Hemodynamics; Male; Myocardium; Rats, Wistar; Resveratrol; Stilbenes; Sulfates; Time Factors | 2014 |
Effects of resveratrol on the expression and DNA methylation of cytokine genes in diabetic rat aortas.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Cytokines; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Angiopathies; DNA Methylation; Gene Expression Regulation; Humans; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Th1-Th2 Balance | 2014 |
Redox regulation of antioxidant enzymes: post-translational modulation of catalase and glutathione peroxidase activity by resveratrol in diabetic rat liver.
Topics: Animals; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glutathione Peroxidase; Humans; Liver; NF-E2-Related Factor 2; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Rats; Resveratrol; Sirtuin 1; Stilbenes; Superoxide Dismutase | 2014 |
Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats.
Topics: Animals; Antioxidants; Blood Glucose; Blood Urea Nitrogen; Catalase; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glutathione; Kidney; Male; Malondialdehyde; Melatonin; Quercetin; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase | 2015 |
Effect of short-term polyphenol treatment on endothelial dysfunction and thromboxane A2 levels in streptozotocin-induced diabetic mice.
Topics: Animals; Antioxidants; Aorta, Thoracic; Chlorogenic Acid; Diabetes Mellitus, Experimental; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Flavonoids; Isometric Contraction; Male; Mice, Inbred ICR; Muscle, Smooth, Vascular; Nitric Oxide; Oxidative Stress; Polyphenols; Resveratrol; Stilbenes; Streptozocin; Thromboxane A2 | 2014 |
Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice.
Topics: Acetylation; Animals; Antioxidants; Apoptosis; Autophagy; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Experimental; Immunoenzyme Techniques; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Oxidation-Reduction; Oxidative Stress; rab GTP-Binding Proteins; rab7 GTP-Binding Proteins; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sirtuin 1; Stilbenes | 2014 |
The effects of resveratrol on tendon healing of diabetic rats.
Topics: Achilles Tendon; Animals; Anti-Inflammatory Agents, Non-Steroidal; Collagen; Diabetes Mellitus, Experimental; Injections, Intraperitoneal; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Tensile Strength; Treatment Outcome; Wound Healing | 2014 |
Cardiac energy metabolism and oxidative stress biomarkers in diabetic rat treated with resveratrol.
Topics: Animals; Antioxidants; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Energy Intake; Energy Metabolism; Fatty Acids, Nonesterified; Glutathione; Male; Myocardium; Oxidative Stress; Rats, Wistar; Resveratrol; Stilbenes | 2014 |
Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests.
Topics: Adaptation, Psychological; Animals; Anti-Anxiety Agents; Anticarcinogenic Agents; Antioxidants; Anxiety; Behavior, Animal; Defecation; Diabetes Mellitus, Experimental; Grooming; Male; Mice; Motor Activity; Resveratrol; Stilbenes; Streptozocin; Time Factors; Urination | 2014 |
Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies.
Topics: Aldehyde Reductase; Animals; Cataract; Cattle; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Imidazolidines; Inhibitory Concentration 50; Kidney Function Tests; Lens, Crystalline; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2014 |
The beneficial effects of combined grape pomace and omija fruit extracts on hyperglycemia, adiposity and hepatic steatosis in db/db mice: a comparison with major index compounds.
Topics: Adiponectin; Adiposity; Animals; Biomarkers; Blood Glucose; Cyclooctanes; Diabetes Mellitus, Experimental; Fatty Liver; Fruit; Glycated Hemoglobin; Hyperglycemia; Insulin; Leptin; Lignans; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Plant Extracts; Polycyclic Compounds; Resistin; Resveratrol; Schisandra; Stilbenes; Vitis | 2014 |
Resveratrol prevents akinesia and restores neuronal tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta of diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Dyskinesias; Male; Motor Activity; Neuroglia; Neurons; Neuroprotective Agents; Pars Compacta; Random Allocation; Rats, Wistar; Resveratrol; Stilbenes; Tyrosine 3-Monooxygenase | 2014 |
Ovarian failure in diabetic rat model: nuclear factor-kappaB, oxidative stress, and pentraxin-3.
Topics: Animals; Antioxidants; C-Reactive Protein; Diabetes Mellitus, Experimental; Female; NF-kappa B; Ovarian Reserve; Ovary; Oxidative Stress; Primary Ovarian Insufficiency; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Serum Amyloid P-Component; Stilbenes | 2014 |
Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling.
Topics: Animal Experimentation; Animals; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred C57BL; Periodontitis; Resveratrol; Signal Transduction; Stilbenes; Toll-Like Receptor 4 | 2015 |
Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-β1-Smad3 signaling pathway.
Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Collagen; Diabetes Mellitus, Experimental; Fibroblasts; Glucose; Mice; Mice, Inbred C57BL; Myocardium; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Smad3 Protein; Stilbenes; Transforming Growth Factor beta1; Up-Regulation | 2015 |
Protective effects of resveratrol against streptozotocin-induced diabetes in rats by modulation of visfatin/sirtuin-1 pathway and glucose transporters.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Dietary Supplements; Glucose Transport Proteins, Facilitative; Hyperglycemia; Hypoglycemic Agents; Male; Malondialdehyde; Muscle, Skeletal; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Pancreas; Phytotherapy; Plant Extracts; Polyphenols; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes; Weight Loss | 2015 |
Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol.
Topics: Animals; Blood Glucose; Cell Movement; Cell Proliferation; Cells, Cultured; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelial Cells; Humans; Isolated Heart Preparation; Male; Microcirculation; Microvessels; Mitochondria; Myocardial Contraction; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Time Factors; Vasodilation | 2015 |
Resveratrol ameliorates the maturation process of β-cell-like cells obtained from an optimized differentiation protocol of human embryonic stem cells.
Topics: Animals; Cell Differentiation; Cell Line; Diabetes Mellitus, Experimental; Embryonic Stem Cells; Heterografts; Humans; Insulin-Secreting Cells; Mice; Mice, Inbred NOD; Mice, SCID; Resveratrol; Stilbenes | 2015 |
Resveratrol Ameliorates Diabetes-Induced Cardiac Dysfunction Through AT1R-ERK/p38 MAPK Signaling Pathway.
Topics: Animals; Diabetes Mellitus, Experimental; Heart Diseases; Male; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Resveratrol; Stilbenes | 2016 |
Resveratrol prevents cardiovascular complications in the SHR/STZ rat by reductions in oxidative stress and inflammation.
Topics: Acetylcholine; Animals; Blood Vessels; Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Drinking; In Vitro Techniques; Inflammation; Lipid Peroxidation; Male; Microelectrodes; Myocardial Contraction; Nitric Oxide; Nitroprusside; Norepinephrine; Oxidative Stress; Rats, Inbred SHR; Resveratrol; Stilbenes; Streptozocin; Ventricular Function | 2015 |
Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner.
Topics: Animals; Antioxidants; Crosses, Genetic; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Enzyme Inhibitors; Female; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Islets of Langerhans; Liver; Male; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Skeletal; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Resveratrol; Sirtuin 1; Stilbenes | 2015 |
Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities.
Topics: AMP-Activated Protein Kinases; Animals; Blotting, Western; Cytokines; Diabetes Mellitus, Experimental; Endothelium, Vascular; Fructose; Gene Expression Regulation; Inflammation; Insulin Resistance; Male; Microscopy, Fluorescence; Nitric Oxide; Phosphorylation; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Vasodilation | 2016 |
Differential gene expression in liver tissues of streptozotocin-induced diabetic rats in response to resveratrol treatment.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Gene Expression Profiling; Hyperglycemia; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2015 |
The cardioprotective effects of resveratrol in rats with simultaneous type 2 diabetes and renal hypertension.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Heart Diseases; Hypertension, Renal; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2015 |
SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diet, High-Fat; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Small Interfering; Sirtuin 1; Stilbenes; Unfolded Protein Response | 2015 |
Resveratrol and sildenafil synergistically improve diabetes-associated erectile dysfunction in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Pressure; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Complications; Diabetes Mellitus, Experimental; Erectile Dysfunction; Male; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Resveratrol; Second Messenger Systems; Sildenafil Citrate; Stilbenes; Sulfonamides | 2015 |
Resveratrol improves hepatic insulin signaling and reduces the inflammatory response in streptozotocin-induced diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Inflammation; Insulin; Liver; Male; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Stilbenes; Streptozocin | 2015 |
Resveratrol regulates oxidative biomarkers and antioxidant enzymes in the brain of streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Frontal Lobe; Gene Expression Regulation, Enzymologic; Glutathione; Male; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2016 |
Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Gliclazide; Glycated Hemoglobin; Hypoglycemic Agents; Losartan; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2015 |
Biochemical and Histopathological Investigation of Resveratrol, Gliclazide, and Losartan Protective Effects on Renal Damage in a Diabetic Rat Model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Gliclazide; Hypoglycemic Agents; Immunohistochemistry; Kidney; Losartan; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2015 |
Melatonin, quercetin and resveratrol attenuates oxidative hepatocellular injury in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Biomarkers; Blood Glucose; Body Weight; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Hepatitis; Hepatocytes; Male; Melatonin; Oxidative Stress; Quercetin; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase | 2015 |
Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3.
Topics: Acetylation; Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Fructosamine; Heart; Histones; Male; NADPH Oxidases; Nitric Oxide; Oxidative Stress; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Superoxide Dismutase; Transcription Factor RelA | 2015 |
Effect of Resveratrol on Leptin and Sirtuin 2 Expression in the Kidneys in Streptozotocin-induced Diabetic Rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Female; Immunohistochemistry; Kidney; Leptin; Rats; Rats, Wistar; Resveratrol; Sirtuin 2; Stilbenes | 2015 |
Effects of Resveratrol on Receptor for Advanced Glycation End Products (RAGE) Expression and Oxidative Stress in the Liver of Rats with Type 2 Diabetes.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Resveratrol; Stilbenes | 2016 |
Resveratrol alleviates diabetes-induced testicular dysfunction by inhibiting oxidative stress and c-Jun N-terminal kinase signaling in rats.
Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Diabetes Mellitus, Experimental; Glutathione Peroxidase; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Stilbenes; Streptozocin; Superoxide Dismutase; Testicular Diseases; Transcription Factor AP-1 | 2015 |
Resveratrol Ameliorates Clonidine-Induced Endothelium-Dependent Relaxation Involving Akt and Endothelial Nitric Oxide Synthase Regulation in Type 2 Diabetic Mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Antioxidants; Clonidine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Synergism; Endothelium, Vascular; Male; Mice, Inbred ICR; Nitric Oxide Synthase; Phosphorylation; Plant Extracts; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; Vasodilation | 2015 |
Resveratrol Ameliorates the Components of Hepatic Inflammation and Apoptosis in a Rat Model of Streptozotocin-Induced Diabetes.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biomarkers; Diabetes Mellitus, Experimental; Erythropoietin; Gene Expression Regulation; Interleukins; Liver; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin; Tumor Necrosis Factor-alpha | 2016 |
Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice.
Topics: Animals; Antioxidants; Cell Adhesion Molecules; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Heart; Male; MAP Kinase Signaling System; Mice; Myocardium; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; Transforming Growth Factor beta | 2016 |
Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol.
Topics: Administration, Oral; Animals; Antioxidants; Biological Availability; Diabetes Mellitus, Experimental; Drug Delivery Systems; Drug Liberation; Emulsions; Excipients; Hypoglycemic Agents; Male; Particle Size; Rats; Rats, Wistar; Resveratrol; Solubility; Stilbenes; Surface-Active Agents; Thermodynamics | 2016 |
Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat.
Topics: Animals; Antioxidants; Autophagy; Blotting, Western; Cell Hypoxia; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Gene Knockdown Techniques; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1; Stilbenes | 2016 |
Silencing of USP22 suppresses high glucose-induced apoptosis, ROS production and inflammation in podocytes.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Cycle Checkpoints; Cell Proliferation; Cytokines; Diabetes Mellitus, Experimental; Disease Models, Animal; Endopeptidases; Gene Expression; Gene Silencing; Glucose; Inflammation Mediators; Matrix Metalloproteinases; Mice; Podocytes; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Ubiquitin Thiolesterase | 2016 |
HRD1-Mediated IGF-1R Ubiquitination Contributes to Renal Protection of Resveratrol in db/db Mice.
Topics: Animals; Biomarkers; Body Weight; Cell Line; Chromatography, Liquid; Diabetes Mellitus, Experimental; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Kidney; Male; Mice, Inbred C57BL; Organ Size; Oxidative Stress; Protective Agents; Protein Binding; Proteolysis; Receptor, IGF Type 1; Resveratrol; RNA, Messenger; Stilbenes; Tandem Mass Spectrometry; Transforming Growth Factor beta; Ubiquitin-Protein Ligases; Ubiquitination | 2016 |
Resveratrol shows neuronal and vascular-protective effects in older, obese, streptozotocin-induced diabetic rats.
Topics: Analgesics; Animals; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hyperalgesia; Male; Muscle Contraction; Nervous System; Obesity; Plant Extracts; Polyphenols; Random Allocation; Rats, Wistar; Resveratrol; Stilbenes | 2016 |
Resveratrol reverses diabetes-related decrement in sildenafil-induced relaxation of corpus cavernosum in aged rats.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Synergism; Erectile Dysfunction; Humans; Male; Nitric Oxide; Penis; Phosphodiesterase 5 Inhibitors; Random Allocation; Rats; Rats, Wistar; Resveratrol; Sildenafil Citrate; Stilbenes | 2017 |
Metformin and resveratrol inhibit Drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice.
Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Apoptosis; Cell Differentiation; Diabetes Mellitus, Experimental; Dynamins; Endoplasmic Reticulum Stress; Gene Expression Regulation; Inflammasomes; Metformin; Mice; Mitochondria; Mitochondrial Dynamics; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphorylation; Reactive Oxygen Species; Resveratrol; Stilbenes | 2016 |
Resveratrol Inhibits Diabetic-Induced Müller Cells Apoptosis through MicroRNA-29b/Specificity Protein 1 Pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blood Glucose; Caspase 3; Cells, Cultured; Diabetes Mellitus, Experimental; Ependymoglial Cells; Fructosamine; Gene Expression Regulation; MicroRNAs; Rats, Sprague-Dawley; Resveratrol; Retina; RNA, Messenger; Sp1 Transcription Factor; Stilbenes | 2017 |
Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Gene Expression Regulation; Glycated Hemoglobin; Kidney; Male; Nerve Tissue Proteins; NF-kappa B; Oxidative Stress; Rats, Wistar; Real-Time Polymerase Chain Reaction; Resveratrol; Rosuvastatin Calcium; Sirtuin 1; Stilbenes; Transforming Growth Factor beta1 | 2016 |
SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis.
Topics: Animals; Apoptosis; Cells, Cultured; Diabetes Mellitus, Experimental; Gene Silencing; Glucose; Humans; Hyperglycemia; Kidney Tubules, Proximal; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes; Streptozocin | 2016 |
Resveratrol limits diabetes-associated cognitive decline in rats by preventing oxidative stress and inflammation and modulating hippocampal structural synaptic plasticity.
Topics: Animals; Antioxidants; Blood Glucose; Cognition; Cognition Disorders; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Experimental; Hippocampus; Inflammation; Male; Maze Learning; Memory; Neuronal Plasticity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Synapses | 2016 |
Sirtuin 1 and 7 mediate resveratrol-induced recovery from hyper-anxiety in high-fructose-fed prediabetic rats.
Topics: Animals; Antioxidants; Anxiety Disorders; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Epigenesis, Genetic; Fructose; Gene Expression Regulation; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Prediabetic State; Rats; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2016 |
Resveratrol Attenuates Copper and Zinc Homeostasis and Ameliorates Oxidative Stress in Type 2 Diabetic Rats.
Topics: Administration, Oral; Animals; Copper; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Homeostasis; Male; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Zinc | 2017 |
Reduced HMGB 1-Mediated Pathway and Oxidative Stress in Resveratrol-Treated Diabetic Mice: A Possible Mechanism of Cardioprotection of Resveratrol in Diabetes Mellitus.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Fibrosis; Heart; HMGB1 Protein; Inflammation; Male; Membrane Glycoproteins; Mice; Monocytes; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Protective Agents; Resveratrol; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Stilbenes | 2016 |
Down-regulation of fibroblast growth factor 2 and its co-receptors heparan sulfate proteoglycans by resveratrol underlies the improvement of cardiac dysfunction in experimental diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Down-Regulation; Fibroblast Growth Factor 2; Gene Expression Regulation; Glypicans; Heart; Heparan Sulfate Proteoglycans; Rats, Wistar; Resveratrol; Stilbenes; Syndecan-4 | 2017 |
Effect of resveratrol on resistin and apelin gene expressions in adipose tissue of diabetic rats.
Topics: Adipose Tissue; Animals; Apelin; Blood Glucose; Diabetes Mellitus, Experimental; Insulin; Rats; Rats, Wistar; Resistin; Resveratrol; Stilbenes | 2016 |
Resveratrol Improves Cognitive Impairment by Regulating Apoptosis and Synaptic Plasticity in Streptozotocin-Induced Diabetic Rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blood Glucose; Blotting, Western; Brain-Derived Neurotrophic Factor; Caspase 3; Cognition Disorders; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Maze Learning; Neuronal Plasticity; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Resveratrol; Stilbenes; Streptozocin; Up-Regulation | 2016 |
Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Male; Niacinamide; Phytoalexins; Rats; Rats, Wistar; Resveratrol; Sesquiterpenes; Stilbenes; Streptozocin; Terpenes | 2008 |
Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats.
Topics: Administration, Oral; Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Evaluation, Preclinical; Fructose-Bisphosphatase; Gliclazide; Glucose-6-Phosphatase; Glucosephosphate Dehydrogenase; Glycogen Phosphorylase; Glycogen Synthase; Hexokinase; Hypoglycemic Agents; Kidney; L-Lactate Dehydrogenase; Liver; Male; Niacinamide; Pyruvate Kinase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2009 |
Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats.
Topics: 5'-Nucleotidase; Adenosine Deaminase; Animals; Blood Platelets; Diabetes Mellitus, Experimental; Male; Platelet Aggregation Inhibitors; Pyrophosphatases; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2009 |
Protective role of SIRT1 in diabetic vascular dysfunction.
Topics: Acetylation; Animals; Aorta; Cells, Cultured; Cellular Senescence; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelial Cells; Endothelium, Vascular; Enzyme Activators; Forkhead Transcription Factors; Glucose; Humans; Mice; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Sirtuin 1; Sirtuins; Stilbenes; Time Factors; Transfection; Tumor Suppressor Protein p53 | 2009 |
Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats.
Topics: Acetylcholinesterase; Animals; Avoidance Learning; Behavior, Animal; Blood Glucose; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Memory; Memory Disorders; Random Allocation; Rats; Resveratrol; Stilbenes; Streptozocin | 2009 |
Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes.
Topics: Adiponectin; Animals; Aorta; Carbon Monoxide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endothelial Cells; Enzyme Induction; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Male; Organometallic Compounds; Protoporphyrins; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin | 2008 |
Improvement of neovascularization capacity of bone marrow mononuclear cells from diabetic mice by ex vivo pretreatment with resveratrol.
Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Bone Marrow Cells; Capillaries; Diabetes Mellitus, Experimental; Heart Rate; Hindlimb; Ischemia; Laser-Doppler Flowmetry; Malondialdehyde; Mice; Mice, Inbred C57BL; Monocytes; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Oxidative Stress; Reactive Oxygen Species; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Superoxide Dismutase; Vascular Endothelial Growth Factor A | 2009 |
Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress.
Topics: Animals; Aorta; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tumor Necrosis Factor-alpha; Vasodilation; Vasodilator Agents | 2009 |
The protease inhibitor UCF-101 ameliorates streptozotocin-induced mouse cardiomyocyte contractile dysfunction in vitro: role of AMP-activated protein kinase.
Topics: Acetylcysteine; AMP-Activated Protein Kinases; Animals; Antioxidants; Calcium-Binding Proteins; Cardiomyopathies; Diabetes Complications; Diabetes Mellitus, Experimental; High-Temperature Requirement A Serine Peptidase 2; In Vitro Techniques; Male; MAP Kinase Signaling System; Mice; Mitochondrial Proteins; Myocardial Contraction; Myocytes, Cardiac; Protease Inhibitors; Pyrimidinones; Resveratrol; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Serine Endopeptidases; Stilbenes; Streptozocin; Thiones; X-Linked Inhibitor of Apoptosis Protein | 2009 |
UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMPK.
Topics: Adenylate Kinase; Animals; Antioxidants; Blood Glucose; Blotting, Western; Caspase 3; Cell Separation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Phosphorylation; Protease Inhibitors; Protein Phosphatase 2; Pyrimidinones; Resveratrol; Stilbenes; Thiones | 2009 |
The effects of resveratrol on cyclooxygenase-1 and cyclooxygenase-2 mRNA and protein levels in diabetic rat kidneys.
Topics: Animals; Body Weight; Cyclooxygenase 1; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Gene Expression Regulation, Enzymologic; Immunohistochemistry; Kidney; Male; Rats; Rats, Wistar; Resveratrol; RNA, Messenger; Software; Stilbenes | 2010 |
Ectonucleotidase and acetylcholinesterase activities in synaptosomes from the cerebral cortex of streptozotocin-induced diabetic rats and treated with resveratrol.
Topics: 5'-Nucleotidase; Acetylcholinesterase; Adenosine Triphosphatases; Animals; Blood Glucose; Body Weight; Cerebral Cortex; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Male; Random Allocation; Rats; Rats, Wistar; Resveratrol; Stilbenes; Synaptosomes | 2009 |
Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.
Topics: Animals; Antioxidants; Cardiomyopathies; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Myocardium; Myocytes, Cardiac; Resveratrol; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sirtuin 1; Stilbenes; Streptozocin; Up-Regulation | 2010 |
Mechanisms underlying vascular effect of chronic resveratrol in streptozotocin-diabetic rats.
Topics: Administration, Oral; Animals; Aorta; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hypoglycemic Agents; Lipid Peroxidation; Liver; Male; Malondialdehyde; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Vasoconstrictor Agents | 2010 |
Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats.
Topics: Animals; Antioxidants; Cytokines; Diabetes Mellitus, Experimental; Gliclazide; Hepatocytes; Hyperglycemia; Hypoglycemic Agents; Inflammation Mediators; Male; Microscopy, Electron, Transmission; Models, Biological; Niacinamide; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2010 |
Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Fasting; Hyperglycemia; Inflammation Mediators; Insulin; Insulin-Secreting Cells; Lipid Peroxides; Male; Niacinamide; Nitric Oxide; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin; Transcription Factor RelA | 2010 |
Resveratrol inhibits neuronal apoptosis and elevated Ca2+/calmodulin-dependent protein kinase II activity in diabetic mouse retina.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Blotting, Western; Body Weight; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Count; Diabetes Mellitus, Experimental; Down-Regulation; Enzyme Inhibitors; In Situ Nick-End Labeling; Male; Mice; Phosphorylation; Resveratrol; Retina; Retinal Ganglion Cells; Signal Transduction; Statistics, Nonparametric; Stilbenes | 2010 |
Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling.
Topics: Analysis of Variance; Animals; Aorta; Blood Glucose; Blotting, Western; Collagen; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glycation End Products, Advanced; Immunohistochemistry; Insulin; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Resveratrol; Signal Transduction; Stilbenes | 2010 |
Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits.
Topics: Acetylcholine; Animals; Antioxidants; Blood Glucose; Body Weight; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Estrogens; Insulin; Lipid Peroxides; Lipids; Male; NADP; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Rabbits; Resveratrol; Stilbenes; Superoxide Dismutase; Testosterone; Time Factors; Vascular Diseases | 2011 |
Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin.
Topics: Acute Disease; Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Drug Antagonism; Drug Evaluation, Preclinical; Drug Synergism; Heart Failure; Hemodynamics; Hypoglycemic Agents; Insulin; Male; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin; Vasodilator Agents | 2010 |
Resveratrol confers endothelial protection in insulin-dependent diabetes mellitus: editorial to: "Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits" by F. Ak
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Male; Oxidative Stress; Resveratrol; Stilbenes; Vascular Diseases | 2011 |
Pan-PPAR agonists based on the resveratrol scaffold: biological evaluation and docking studies.
Topics: Animals; Binding Sites; Cell Line, Tumor; Computer Simulation; Diabetes Mellitus, Experimental; Dietary Fats; Disease Models, Animal; Humans; Mice; Pentanoic Acids; PPAR alpha; PPAR delta; PPAR gamma; Protein Structure, Tertiary; Resveratrol; Stilbenes | 2010 |
The combination of bortezomib and resveratrol may prevent muscle wasting in diabetes.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Boronic Acids; Bortezomib; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Humans; Inflammation; Models, Biological; Muscular Atrophy; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Rats; Resveratrol; Stilbenes | 2011 |
Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: prelimin
Topics: Animals; Antioxidants; Cyclic GMP; Diabetes Mellitus, Experimental; Erectile Dysfunction; Imidazoles; Male; Muscle, Smooth; Nitric Oxide; Nitric Oxide Synthase Type III; Penis; Phosphodiesterase 5 Inhibitors; Piperazines; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Sulfones; Triazines; Vardenafil Dihydrochloride | 2011 |
Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
Topics: Animals; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Hypoglycemic Agents; Kidney; Male; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Smad Proteins; Stilbenes; Transforming Growth Factor beta | 2011 |
Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats.
Topics: Analysis of Variance; Animals; Antioxidants; Arterioles; Blotting, Western; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dose-Response Relationship, Drug; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Pia Mater; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides; Vasodilation; Vasodilator Agents | 2011 |
Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.
Topics: AMP-Activated Protein Kinases; Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Gene Expression; Male; Oxidative Stress; Rats; Rats, Long-Evans; Resveratrol; Stilbenes | 2011 |
Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.
Topics: Animals; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cell Line; Chemokine CCL2; Chemotaxis, Leukocyte; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Humans; Hyperlipidemias; Kidney; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Oxidative Stress; Receptors, CCR2; Receptors, LDL; Resveratrol; Stilbenes; Time Factors; Triterpenes; Ursolic Acid | 2011 |
Resveratrol ameliorates metabolic disorders and muscle wasting in streptozotocin-induced diabetic rats.
Topics: Adenylate Kinase; Animals; Antioxidants; Cytokines; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Male; Metabolic Diseases; Models, Biological; Muscle, Skeletal; Muscular Diseases; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Streptozocin; Wasting Syndrome | 2011 |
Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Biomarkers; Catalase; Diabetes Mellitus, Experimental; gamma-Glutamyltransferase; Kidney; Lipid Peroxidation; Liver; Male; Oxidative Stress; Porphobilinogen Synthase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2012 |
Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Glucose; Blood-Retinal Barrier; Blotting, Western; Body Weight; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Male; Mice; Mice, Inbred C57BL; Pericytes; Resveratrol; Retina; Retinal Vessels; Stilbenes; Vascular Endothelial Growth Factor A | 2012 |
Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation.
Topics: Administration, Oral; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Inflammation; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Phosphorylation; Resveratrol; Retinitis; Ribonucleotides; Sirtuin 1; Stilbenes; Transcription Factor RelA; Vascular Endothelial Growth Factor A | 2011 |
Novel phenoxyalkylcarboxylic acid derivatives as hypolipidaemic agents.
Topics: Animals; Carboxylic Acids; Cholesterol; Diabetes Mellitus, Experimental; Fenofibrate; Flavonoids; Hyperlipidemias; Hypolipidemic Agents; Magnetic Resonance Spectroscopy; Male; Mice; Models, Molecular; Molecular Structure; Polyethylene Glycols; Resveratrol; Stilbenes; Surface-Active Agents; Triglycerides | 2012 |
The effects of resveratrol on cyclooxygenase-1 and -2, nuclear factor kappa beta, matrix metalloproteinase-9, and sirtuin 1 mRNA expression in hearts of streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Cardiomyopathies; Cyclooxygenase 1; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression Regulation; Heart; Male; Matrix Metalloproteinase 9; NF-kappa B; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Messenger; Signal Transduction; Sirtuin 1; Stilbenes | 2011 |
Investigation of ocular neovascularization-related genes and oxidative stress in diabetic rat eye tissues after resveratrol treatment.
Topics: Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Eye; Male; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Nitrates; Nitric Oxide Synthase Type III; Nitrites; Oxidative Stress; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Messenger; Stilbenes; Streptozocin; Vascular Endothelial Growth Factor A | 2012 |
Chronic resveratrol administration has beneficial effects in experimental model of type 2 diabetic rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Hyperglycemia; Male; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase | 2012 |
Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Weight; Cells, Cultured; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Ganglia, Spinal; Gene Expression Regulation; Green Fluorescent Proteins; Hyperalgesia; Male; Membrane Potentials; Mice; Mitochondrial Diseases; Mitochondrial Membranes; Mutation; Nerve Fibers, Myelinated; Neurites; Oxygen Consumption; Patch-Clamp Techniques; Peripheral Nervous System Diseases; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reaction Time; Resveratrol; RNA-Binding Proteins; Sensory Receptor Cells; Signal Transduction; Stilbenes; Transcription Factors; Transduction, Genetic | 2012 |
Protective effect of ferulic acid and resveratrol against alloxan-induced diabetes in mice.
Topics: Active Transport, Cell Nucleus; Animals; Antioxidants; Biomarkers; Cell Nucleus; Coumaric Acids; Diabetes Mellitus, Experimental; Disease Progression; Kidney; Lipid Peroxidation; Liver; Mice; NF-kappa B; Pancreas; Resveratrol; Stilbenes | 2012 |
Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Lipid Peroxidation; Lipids; Liver; Liver Diseases; Male; Malondialdehyde; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin | 2012 |
Moderate red wine and grape juice consumption modulates the hydrolysis of the adenine nucleotides and decreases platelet aggregation in streptozotocin-induced diabetic rats.
Topics: 5'-Nucleotidase; Adenine Nucleotides; Adenosine Deaminase; Animals; Antioxidants; Beverages; Blood Platelets; Caffeic Acids; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hydrolysis; Male; Plant Preparations; Platelet Aggregation; Pyrophosphatases; Quercetin; Rats; Rats, Wistar; Resveratrol; Rutin; Stilbenes; Vitis; Wine | 2013 |
Long-term treatment with resveratrol attenuates oxidative stress pro-inflammatory mediators and apoptosis in streptozotocin-nicotinamide-induced diabetic rats.
Topics: Animals; Apoptosis; Cytokines; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Inflammation Mediators; Longitudinal Studies; Male; Niacinamide; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin; Treatment Outcome | 2012 |
Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Catalase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glutathione; Kidney; Kidney Function Tests; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Phenols; Phytoalexins; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Resveratrol; Sesquiterpenes; Stilbenes; Superoxide Dismutase; Terpenes | 2006 |
Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Synergism; Glucose; Glycogen; Hepatocytes; Hyperglycemia; Insulin; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Time Factors; Wine | 2006 |
Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Genistein; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Resveratrol; Stilbenes; Tissue Culture Techniques | 2006 |
Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Cold Temperature; Diabetes Mellitus, Experimental; Hot Temperature; Hyperalgesia; Immersion; Male; Phytoalexins; Plant Extracts; Rats; Rats, Sprague-Dawley; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes | 2006 |
Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Apigenin; Atherosclerosis; Benzopyrans; Carcinoma, Hepatocellular; Cell Line, Tumor; Diabetes Mellitus, Experimental; Enzyme Activation; Flavonoids; Glucose; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipids; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Multienzyme Complexes; Phenols; Phosphorylation; Polyphenols; Protein Serine-Threonine Kinases; Receptors, LDL; Resveratrol; Stilbenes | 2006 |
Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Therapy, Combination; Hot Temperature; Insulin; Male; Mice; Nitric Oxide; Pain; Pain Measurement; Phytotherapy; Plant Extracts; Plants, Medicinal; Resveratrol; Stilbenes; Streptozocin; Tumor Necrosis Factor-alpha | 2007 |
Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Topics: Analgesics, Non-Narcotic; Animals; Brain; Diabetes Mellitus, Experimental; Hot Temperature; Hyperalgesia; Male; Mice; Mice, Inbred Strains; Neuralgia; Nitric Oxide; Pain Threshold; Phytoalexins; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes; Tumor Necrosis Factor-alpha | 2007 |
Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats.
Topics: Animals; Central Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Free Radical Scavengers; Glutathione; Hyperglycemia; Lipid Peroxidation; Male; Malondialdehyde; Medulla Oblongata; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Spinal Cord; Stilbenes; Vasodilator Agents; Xanthine Oxidase | 2007 |
Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; DNA Fragmentation; Dose-Response Relationship, Drug; Humans; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Neural Conduction; Oxidative Stress; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Resveratrol; Sciatic Nerve; Stilbenes | 2007 |
Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats.
Topics: Androstadienes; Animals; Antioxidants; Blood Glucose; Carboxy-Lyases; Chromones; Diabetes Mellitus, Experimental; Glucose Transporter Type 4; Hypoglycemic Agents; Liver; Male; Morpholines; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Stilbenes; Vitis; Wortmannin | 2007 |
Resveratrol enhances insulin secretion by blocking K(ATP) and K(V) channels of beta cells.
Topics: Animals; Blood Glucose; Cell Line, Tumor; Cricetinae; Diabetes Mellitus, Experimental; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Membrane Potentials; Mice; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2007 |
Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.
Topics: Animals; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Gene Expression Regulation; Heart Diseases; Heme Oxygenase (Decyclizing); In Situ Nick-End Labeling; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; RNA, Messenger; Stilbenes; Streptozocin; Superoxide Dismutase; Thioredoxins; Vascular Endothelial Growth Factor A | 2007 |
Pretreatment effect of resveratrol on streptozotocin-induced diabetes in rats.
Topics: Animals; Antioxidants; Catalase; Copper; Diabetes Mellitus, Experimental; Male; Malondialdehyde; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin; Zinc | 2007 |
Resveratrol: is there any effect on healthy subject?
Topics: Animals; Antioxidants; Catalase; Copper; Diabetes Mellitus, Experimental; Humans; Male; Malondialdehyde; Nitric Oxide; Nitrogen; Oxygen; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes; Zinc | 2007 |
Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium.
Topics: AMP-Activated Protein Kinases; Animals; Biological Transport, Active; Blood Glucose; Caveolae; Caveolin 1; Caveolin 3; Deoxyglucose; Diabetes Mellitus, Experimental; Glucose Transporter Type 4; Immunohistochemistry; In Vitro Techniques; Male; Myocardium; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2008 |
Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Histones; Male; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Streptozocin; Tumor Suppressor Protein p53 | 2008 |
The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood Glucose; Blood Vessels; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelium, Vascular; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroprusside; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Thoracic Arteries; Vasoconstrictor Agents; Vasodilator Agents | 2008 |